Stuart Lowther on how ELMT’s new plant-based JAKTRX™ Pro Amino may improve muscle protein synthesis by 76%
In a recent InvestorIntel interview, Tracy Weslosky spoke with Stuart Lowther, President, CEO and Founder of Element Nutritional Sciences Inc. (CSE: ELMT) about how Element’s new plant-based amino acid formulation for the sports nutrition market is better than whey protein.
In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Stuart said that the first product to be launched in the United States using the new formulation will be JAKTRX™ Pro Amino which is estimated to improve muscle protein synthesis by 76%. Stuart also provided an update on the formation of Element’s Medical Advisory Board which will help develop higher dosage Rejuvenate™ formulations to slow muscle loss in orthopedic and oncology patients.
To watch the full interview, click here.
About Element Nutritional Sciences Inc.
Element is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on men and women over the age of 50. Element’s lead product, Rejuvenate™, is a proprietary formulation that is clinically proven to assist in the rebuilding, restoration and rejuvenation of natural loss of muscle mass due to aging or other medical conditions. Element also offers JAKTRX™, an elite brand of performance supplements. Element was founded in 2015 and is located in Burlington, Ontario.
To learn more about Element Nutritional Sciences Inc., click here
Disclaimer: Element Nutritional Sciences Inc. is an advertorial member of InvestorIntel Corp.
This interview, which was produced by InvestorIntel Corp. (IIC) does not contain, nor does it purport to contain, a summary of all the material information concerning the “Company” being interviewed. IIC offers no representations or warranties that any of the information contained in this interview is accurate or complete.
This presentation may contain “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements are based on the opinions and assumptions of management of the Company as of the date made. They are inherently susceptible to uncertainty and other factors that could cause actual events/results to differ materially from these forward-looking statements. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company’s business or any investment therein.
Any projections given are principally intended for use as objectives and are not intended, and should not be taken, as assurances that the projected results will be obtained by the Company. The assumptions used may not prove to be accurate and a potential decline in the Company’s financial condition or results of operations may negatively impact the value of its securities. Prospective investors are urged to review the Company’s profile on www.Sedar.com and to carry out independent investigations in order to determine their interest in investing in the Company.
If you have any questions surrounding the content of this interview, please email firstname.lastname@example.org.